Enhancements    

IDENTIFICATION OF A LEAD MJC13 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER

IDENTIFICATION OF A LEAD MJC13 FAMILY COMPOUND FOR THE TREATMENT OF PROSTATE CANCER
PI: Marc Cox
Sponsor: MAIA BIOTECHNOLOGY
Biological Sciences
Amount awarded: $46,000

This project synthesizes lead candidates with the goal of increasing efficacy, reducing toxicity, and ensuring bioavailability of the compound of MUC13 and assesses ease of preparation, potential amenability to parallel synthesis and the ability to generate diversity from late-stage intermediates.

Posting date: Wed, 01/23/2019

Award start date: Tue, 01/01/2019
Award end date: Tue, 12/31/2019